<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002882.ref050">
 <label>50</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Sterling</surname>
   <given-names>TR</given-names>
  </name>, 
  <name>
   <surname>Villarino</surname>
   <given-names>ME</given-names>
  </name>, 
  <name>
   <surname>Borisov</surname>
   <given-names>AS</given-names>
  </name>, 
  <name>
   <surname>Shang</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>Gordin</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Bliven-Sizemore</surname>
   <given-names>E</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Three months of rifapentine and isoniazid for latent tuberculosis infection</article-title>. 
  <source>N Engl J Med</source>. 
  <year>2011</year>;
  <volume>365</volume>(
  <issue>23</issue>):
  <fpage>2155</fpage>â€“
  <lpage>66</lpage>. Epub 2011/12/14. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1104875</pub-id> .
  <?supplied-pmid 22150035?>
  <pub-id pub-id-type="pmid">22150035</pub-id>
 </mixed-citation>
</ref>
